Skip to main content Back to Top
Advertisement

10/18/2019

Amobarbital Sodium Injection

Products Affected - Description

    • Amytal lyophilized powder for injection, Bausch Health, 500 mg, vial, 1 count, NDC 00187-4303-05

Reason for the Shortage

    • Bausch Health did not provide a reason for the shortage. They are the sole suppliers of amobarbital injection.

Available Products

    • There are no presentations available

Estimated Resupply Dates

    • Bausch Health has Amytal 500 mg vials on back order and the company estimates a release date of late-February 2020.

Updated

Created October 18, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins